Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris
Public ClinicalTrials.gov record NCT01320033. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi Center, Randomized, Double Blind, Placebo Controlled, 3 Arm, Parallel Group Study Comparing the Efficacy and Safety of CD2475/101 40 mg Tablets Versus Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions in Subjects With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objectives of the study is to show CD2475/101 40mg tablets taken once a day for 16 weeks is superior to the placebo in Change from baseline to Week 16(Last Observation Carry Forward, Intent To Treat) in inflammatory lesion counts.
Study identification
- NCT ID
- NCT01320033
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 662 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 29, 2011 (Actual)
- Primary completion
- Jan 3, 2012 (Actual)
- Completion
- Jan 3, 2012 (Actual)
- Last update posted
- Feb 18, 2021
2011 – 2012
United States locations
- U.S. sites
- 31
- U.S. states
- 21
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Dermatology Research Associates, Inc. | Los Angeles | California | 90045 | — |
| Colorado Medical Research Center | Denver | Colorado | 80210 | — |
| Longmont Medical Research Network | Longmont | Colorado | 80501 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Dermatology Specialists PC | Louisville | Kentucky | 40202 | — |
| Somerset Skin Care Center | Troy | Michigan | 48084 | — |
| Grekin Skin Care | Warren | Michigan | 48088 | — |
| Central Dermatology, PC | St Louis | Missouri | 63117 | — |
| Skin Specialists, PC | Omaha | Nebraska | 68144 | — |
| Academic Dermatology | Albuquerque | New Mexico | 87106 | — |
| Helendale Dermatology & Medical Spa | Rochester | New York | 14609 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| PMG Research of Wilmington | Wilmington | North Carolina | 28401 | — |
| Haber Dermatology & cosmetic Surgery, Inc | South Euclid | Ohio | 44118 | — |
| Central Sooner Research | Norman | Oklahoma | 73069 | — |
| Oregon Dermatology & Research Center | Portland | Oregon | 97210 | — |
| Stephen Schleicher | Hazleton | Pennsylvania | 18201 | — |
| Palmetto Clinical Trial Services, LLC | Greenville | South Carolina | 29607 | — |
| Dermatology Research Associates | Nashville | Tennessee | 37203 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Arlington Center for Dermatology | Arlington | Texas | 76011 | — |
| Derm Research, Inc | Austin | Texas | 78759 | — |
| J&S Studies | College Station | Texas | 77845 | — |
| Suzanne Bruce and associates P.A. The Center for skin Research | Houston | Texas | 77056 | — |
| Center for Clinical Studies | Houston | Texas | 77058 | — |
| Progressive Clinical Research | San Antonio | Texas | 78229 | — |
| Stephen Miller MD | San Antonio | Texas | 78229 | — |
| Dermatology Research Center | Salt Lake City | Utah | 84124 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01320033, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 18, 2021 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01320033 live on ClinicalTrials.gov.